『徳島大学 教育・研究者情報データベース (EDB)』---[学外] /
ID: Pass:

登録内容 (EID=386674)

EID=386674EID:386674, Map:0, LastModified:2022年7月21日(木) 10:53:50, Operator:[吉川 幸造], Avail:TRUE, Censor:0, Owner:[吉川 幸造], Read:継承, Write:継承, Delete:継承.
種別 (必須): 学術論文 (紀要その他) [継承]
言語 (必須): 英語 [継承]
招待 (推奨):
審査 (推奨):
カテゴリ (推奨):
共著種別 (推奨):
学究種別 (推奨):
組織 (推奨):
著者 (必須): 1. (英) Gao Luping (日) 高 露萍 (読) こう ろへい
役割 (任意):
貢献度 (任意):
学籍番号 (推奨): **** [ユーザ]
[継承]
2.森根 裕二 ([徳島大学.大学院医歯薬学研究部.医学域.医科学部門.外科系.消化器・移植外科学]/[徳島大学.病院.診療科.外科.消化器・移植外科])
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
3.山田 眞一郎 ([徳島大学.病院.診療科.外科.消化器・移植外科])
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
4.齋藤 裕 ([徳島大学.病院.先端医科医療開発研究プロジェクト]/[徳島大学.病院.診療科.外科.消化器・移植外科])
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
5.池本 哲也 ([徳島大学.病院.中央診療施設等.安全管理部]/[徳島大学.病院.診療科.外科.消化器・移植外科])
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
6.徳田 和憲 ([徳島大学.病院.診療科.第一外科])
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
7.宮崎 克己 ([徳島大学.病院.診療科.第一外科])
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
8. (英) Okikawa Shouhei (日) (読)
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
9.髙須 千絵 ([徳島大学.大学院医歯薬学研究部.医学域.医科学部門.外科系.消化器・移植外科学])
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
10.島田 光生 ([徳島大学.大学院医歯薬学研究部.医学域.医科学部門.外科系.消化器・移植外科学])
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
題名 (必須): (英) The BAFF/NF B axis is crucial to interactions between sorafenib-resistant HCC cells and cancer-associated fibroblasts.  (日)    [継承]
副題 (任意):
要約 (任意): (英) The tumor microenvironment affects malignancy in hepatocellular carcinoma (HCC) cells, and cancer-associated fibroblasts (CAFs) play an important role in the microenvironment. As recent studies indicated a difference between CAFs isolated from chemoresistant and non-resistant cancer tissues, therefore we investigated the intracellular mechanism in resistant HCC co-cultured CAFs and interactions between these CAFs with cancer cells. We established a sorafenib-resistant (SR) Huh7 (human HCC) cell line, and characterized it with cytokine assays, then developed CAFs by co-culturing human hepatic stellate cells with resistant or parental Huh7 cells. The 2 types of CAFs were co-cultured with parental Huh7 cells, thereafter the cell viability of these Huh7 cells was checked under sorafenib treatment. The SR Huh7 (Huh7 ) cells expressed increased B-cell activating factor (BAFF), which promoted high expression of CAF-specific markers in Huh7 -co-cultured CAFs, showed activated BAFF, BAFF-R, and downstream of the NF B-Nrf2 pathway, and aggravated invasion, migration, and drug resistance in co-cultured Huh7 cells. When we knocked down BAFF expression in Huh7 cells, the previously increased malignancy and BAFF/NF B axis in Huh7 -co-cultured CAFs reversed, and enhanced chemoresistance in co-cultured Huh7 cells returned as well. In conclusion, the BAFF/NF B pathway was activated in CAFs co-cultured with cell-culture medium from resistant Huh7, which promoted chemoresistance, and increased the malignancy in co-cultured non-resistant Huh7 cells. This suggests that the BAFF/NF B axis in CAFs might be a potential therapeutic target in chemoresistance of HCC.  (日)    [継承]
キーワード (推奨): 1. (英) Antineoplastic Agents (日) (読) [継承]
2. (英) B-Cell Activating Factor (日) (読) [継承]
3. (英) Cancer-Associated Fibroblasts (日) (読) [継承]
4. (英) Carcinoma, Hepatocellular (日) (読) [継承]
5. (英) Cell Communication (日) (読) [継承]
6. (英) Cell Line, Tumor (日) (読) [継承]
7. (英) Cell Movement (日) (読) [継承]
8. (英) Cell Survival (日) (読) [継承]
9. (英) Coculture Techniques (日) (読) [継承]
10. (英) Drug Resistance, Neoplasm (日) (読) [継承]
11. (英) Gene Knockdown Techniques (日) (読) [継承]
12. (英) Humans (日) (読) [継承]
13. (英) Liver Neoplasms (日) (読) [継承]
14. (英) NF-kappa B (日) (読) [継承]
15. (英) Signal Transduction (日) (読) [継承]
16. (英) Sorafenib (日) (読) [継承]
17. (英) Transfection (日) (読) [継承]
発行所 (推奨):
誌名 (必須): Cancer Science ([日本癌学会])
(pISSN: 1347-9032, eISSN: 1349-7006)

ISSN (任意): 1349-7006
ISSN: 1347-9032 (pISSN: 1347-9032, eISSN: 1349-7006)
Title: Cancer science
Title(ISO): Cancer Sci
Publisher: Wiley-Blackwell
 (NLM Catalog  (医中誌Web  (Scopus  (CrossRef (Scopus information is found. [need login])
[継承]
[継承]
(必須): 112 [継承]
(必須): 9 [継承]
(必須): 3545 3554 [継承]
都市 (任意):
年月日 (必須): 西暦 2021年 7月 16日 (令和 3年 7月 16日) [継承]
URL (任意):
DOI (任意): 10.1111/cas.15041    (→Scopusで検索) [継承]
PMID (任意): 34159680    (→Scopusで検索) [継承]
CRID (任意):
WOS (任意):
Scopus (任意):
評価値 (任意):
被引用数 (任意):
指導教員 (推奨):
備考 (任意): 1.(英) Article.ELocationID: 10.1111/cas.15041  (日)    [継承]
2.(英) Article.PublicationTypeList.PublicationType: Journal Article  (日)    [継承]
3.(英) KeywordList.Keyword: B-cell activating factor  (日)    [継承]
4.(英) KeywordList.Keyword: cancer-associated fibroblasts  (日)    [継承]
5.(英) KeywordList.Keyword: drug resistance  (日)    [継承]
6.(英) KeywordList.Keyword: hepatocellular carcinoma  (日)    [継承]
7.(英) KeywordList.Keyword: sorafenib  (日)    [継承]

標準的な表示

和文冊子 ● Luping Gao, Yuji Morine, Shin-ichiro Yamada, Yu Saitou, Tetsuya Ikemoto, Kazunori Tokuda, Katsuki Miyazaki, Shouhei Okikawa, Chie Takasu and Mitsuo Shimada : The BAFF/NF B axis is crucial to interactions between sorafenib-resistant HCC cells and cancer-associated fibroblasts., Cancer Science, Vol.112, No.9, 3545-3554, 2021.
欧文冊子 ● Luping Gao, Yuji Morine, Shin-ichiro Yamada, Yu Saitou, Tetsuya Ikemoto, Kazunori Tokuda, Katsuki Miyazaki, Shouhei Okikawa, Chie Takasu and Mitsuo Shimada : The BAFF/NF B axis is crucial to interactions between sorafenib-resistant HCC cells and cancer-associated fibroblasts., Cancer Science, Vol.112, No.9, 3545-3554, 2021.

関連情報

Number of session users = 0, LA = 0.98, Max(EID) = 394928, Max(EOID) = 1070970.